EDXC — Endexx Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $2.97m
- $14.37m
- $2.14m
Annual income statement for Endexx, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K/A |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.745 | 1.11 | 1.15 | 0.651 | 2.14 |
Cost of Revenue | |||||
Gross Profit | 0.263 | -0.497 | 0.341 | -0.344 | 1.19 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.27 | 5.4 | 5.32 | 6.02 | 6.05 |
Operating Profit | -1.53 | -4.29 | -4.17 | -5.37 | -3.92 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.5 | -8.28 | -9.16 | -6.81 | -5.14 |
Net Income After Taxes | -2.5 | -8.28 | -9.16 | -6.81 | -5.14 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.5 | -8.28 | -9.16 | -6.81 | -4.88 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.5 | -8.28 | -9.16 | -6.81 | -4.88 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.022 | -0.023 | -0.015 | -0.01 |